Vanguard Group’s Applied Therapeutics APLT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.47M Sell
4,734,013
-1,155,180
-20% -$359K ﹤0.01% 3637
2025
Q1
$2.88M Buy
5,889,193
+340,962
+6% +$167K ﹤0.01% 3363
2024
Q4
$4.75M Buy
5,548,231
+305,282
+6% +$261K ﹤0.01% 3292
2024
Q3
$44.6M Sell
5,242,949
-79,511
-1% -$676K ﹤0.01% 2227
2024
Q2
$24.9M Buy
5,322,460
+2,312,170
+77% +$10.8M ﹤0.01% 2459
2024
Q1
$20.5M Sell
3,010,290
-220,191
-7% -$1.5M ﹤0.01% 2584
2023
Q4
$10.8M Buy
3,230,481
+1,801,827
+126% +$6.04M ﹤0.01% 2901
2023
Q3
$3.56M Buy
1,428,654
+431,652
+43% +$1.07M ﹤0.01% 3388
2023
Q2
$1.28M Buy
997,002
+141,847
+17% +$182K ﹤0.01% 3824
2023
Q1
$694K Buy
855,155
+58,593
+7% +$47.5K ﹤0.01% 4021
2022
Q4
$605K Buy
796,562
+343,299
+76% +$261K ﹤0.01% 4048
2022
Q3
$422K Sell
453,263
-60,956
-12% -$56.8K ﹤0.01% 4258
2022
Q2
$488K Sell
514,219
-96,648
-16% -$91.7K ﹤0.01% 4303
2022
Q1
$1.29M Sell
610,867
-240,271
-28% -$507K ﹤0.01% 4129
2021
Q4
$7.62M Buy
851,138
+839
+0.1% +$7.51K ﹤0.01% 3380
2021
Q3
$14.1M Buy
850,299
+5,417
+0.6% +$89.9K ﹤0.01% 3052
2021
Q2
$17.6M Buy
844,882
+10,713
+1% +$223K ﹤0.01% 2915
2021
Q1
$15.6M Buy
834,169
+152,605
+22% +$2.86M ﹤0.01% 2920
2020
Q4
$15M Buy
681,564
+887
+0.1% +$19.5K ﹤0.01% 2782
2020
Q3
$14.1M Buy
680,677
+65,157
+11% +$1.35M ﹤0.01% 2611
2020
Q2
$22.3M Buy
615,520
+67,462
+12% +$2.44M ﹤0.01% 2370
2020
Q1
$17.9M Buy
548,058
+208,162
+61% +$6.81M ﹤0.01% 2346
2019
Q4
$9.27M Buy
339,896
+304,932
+872% +$8.32M ﹤0.01% 2895
2019
Q3
$384K Buy
+34,964
New +$384K ﹤0.01% 3868